{
  "report_rows": [
    {
      "kpi": "Adj. EBITDA (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$527M vs. cons $516M (+2.1%)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Revenue (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$2,625M vs. cons $2,606M (+0.7%)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. Operating EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$0.71 vs. cons $0.662 (+7.2%)",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Revenue (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide reaffirm $10.5B-$10.8B vs. cons $10.505B",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY 2026 Adj. EBITDA (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide reaffirm $2.05B-$2.15B vs. cons $2.074B",
      "confidence": "HIGH"
    },
    {
      "kpi": "Food Ingredients Divestiture",
      "prediction": "BETTER",
      "answer": "deal signed/advanced vs. no deal in estimates",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.5,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 Archetype B: beat + maintain triggers estimate drift lower as H2 burden becomes visible; short-covering provides a floor vs. worst historical outcomes",
  "day5_confidence": "MEDIUM"
}